BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krovi SA, Johnson LM, Luecke E, Achilles SL, van der Straten A. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention. Adv Drug Deliv Rev 2021;176:113849. [PMID: 34186143 DOI: 10.1016/j.addr.2021.113849] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Little KM, Flomen L, Hanif H, Anderson SM, Thurman AR, Clark MR, Doncel GF. HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa. AIDS Behav 2022. [PMID: 35360893 DOI: 10.1007/s10461-022-03658-w] [Reference Citation Analysis]
2 Palanee-Phillips T, Baum MM, Moss JA, Clark MR, Nuttall J, Romano JW. Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: A review of recent advances and clinical applications. Expert Opin Drug Deliv 2021. [PMID: 34958283 DOI: 10.1080/17425247.2022.2020242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Witte SS, Filippone P, Ssewamala FM, Nabunya P, Bahar OS, Mayo-Wilson LJ, Namuwonge F, Damulira C, Tozan Y, Kiyingi J, Nabayinda J, Mwebembezi A, Kagaayi J, McKay M. PrEP acceptability and initiation among women engaged in sex work in Uganda: Implications for HIV prevention. EClinicalMedicine 2022;44:101278. [PMID: 35128367 DOI: 10.1016/j.eclinm.2022.101278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li L, Gatto GJ, Brand RM, Krovi SA, Cottrell ML, Norton C, van der Straten A, Johnson LM. Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones. J Control Release 2021;340:188-99. [PMID: 34678316 DOI: 10.1016/j.jconrel.2021.10.021] [Reference Citation Analysis]
5 das Neves J, Ensign L. Advances in drug delivery for women's health: A matter of gender equity. Adv Drug Deliv Rev 2022;182:114132. [PMID: 35090956 DOI: 10.1016/j.addr.2022.114132] [Reference Citation Analysis]